Figure 6
Figure 6. Proportion of human CD45+/GFP+ in the peripheral blood of ALL-11 engrafted mice at event. PB from mice engrafted with untransduced (A), empty vector (B), or AKR1C3 cDNA (C) ALL-11 cells was collected when mice reached event (hCD45+ population in blood reaches 25%). One representative mouse is shown from each. The hCD45+ population was gated by flow cytometry to determine the proportion of GFP+ cells circulating in the PR-104–treated (blue) or vehicle (red) groups. The numbers in panels A through C refer to the percentage of GFP− and GFP+ cells in the PR-104–treated mice. (D) Quantification of the proportion of hCD45+/GFP+ cells in all groups.

Proportion of human CD45+/GFP+ in the peripheral blood of ALL-11 engrafted mice at event. PB from mice engrafted with untransduced (A), empty vector (B), or AKR1C3 cDNA (C) ALL-11 cells was collected when mice reached event (hCD45+ population in blood reaches 25%). One representative mouse is shown from each. The hCD45+ population was gated by flow cytometry to determine the proportion of GFP+ cells circulating in the PR-104–treated (blue) or vehicle (red) groups. The numbers in panels A through C refer to the percentage of GFP and GFP+ cells in the PR-104–treated mice. (D) Quantification of the proportion of hCD45+/GFP+ cells in all groups.

Close Modal

or Create an Account

Close Modal
Close Modal